Skip to search formSkip to main contentSkip to account menu

NE 10064

Known as: NE-10064 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Introduction. Drugs with class III antiarrhythmic properties generally decrease defibrillation threshold (DFT). However, the… 
2004
2004
BACKGROUND Azimilide reportedly blocks Na(+) channels, although its mechanism remains unclear. METHODS AND RESULTS The kinetic… 
1998
1998
  • G. Gintant
  • Journal of cardiovascular pharmacology
  • 1998
  • Corpus ID: 24275311
Most class III antiarrhythmic drugs reduce the rapidly activating component of delayed-rectifier current (IKr) without affecting… 
1997
1997
Azimilide Effects on Membrane Voltage and Current. Introduction: Azimilide (NE‐10064) has antiarrhythmic and antifibrillatory… 
1997
1997
Rate Dependence of Azimilide and E‐4031. Introduction: Reverse rate‐dependence, a lessening in Class III antiarrhythmic agent… 
1996
1996
We have investigated the concentration-dependent modulation, by the novel class III antiarrhythmic compound NE-10064, of the… 
Highly Cited
1995
Highly Cited
1995
We studied the effects of NE-10064 (azimilide), a new antiarrhythmic agent reported to be a selective blocker of the slowly… 
Highly Cited
1994
Highly Cited
1994
Slowly activating, voltage-dependent IsK channels were expressed in Xenopus oocytes after injection of rat IsK protein cRNA and… 
1994
1994
Summary: The electrophysiologic effects of a new antiarrhythmic agent NE-10064 were compared with known class III drugs, E-4031… 
Highly Cited
1993
Highly Cited
1993
Summary: The electrophysiologic and antifibrillatory properties of NE-10064 were studied in vivo in a conscious canine model of…